Ozempic vs Bydureon

Quick Facts

  • Type: GLP-1
  • FDA Approval: Ozempic (2017), Bydureon (2012)
  • Frequency: Once weekly

Weight Loss Data

  • Ozempic: 12-14% in 68 weeks
  • Bydureon: 2-4% in 24 weeks

Primary Uses

  • Type 2 Diabetes
  • Weight Management
  • Cardiovascular Risk Reduction

Medication Overview

Ozempic

GLP-1

Basic Information

  • Generic Name: semaglutide
  • Manufacturer: Novo Nordisk
  • FDA Approval: 2017

Key Benefits

  • Significant A1C reduction
  • Weight loss support
  • Cardiovascular benefits
  • Once-weekly dosing

Bydureon

GLP-1

Basic Information

  • Generic Name: exenatide extended-release
  • Manufacturer: AstraZeneca
  • FDA Approval: 2012

Key Benefits

  • Once-weekly dosing
  • No dose titration needed
  • Steady medication levels
  • Established safety profile

Dosing Information

Dosing DetailsOzempicBydureon
Starting Dose0.25mg2mg
Maintenance Dose0.5mg to 1mg2mg
Maximum Dose2mg2mg
ScheduleInject once weekly on the same day each weekInject once weekly at any time of day
TitrationStart with 0.25mg for 4 weeks, then 0.5mg for at least 4 weeks before increasing if neededNo titration required, fixed 2mg dose

Side Effects

Ozempic

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Constipation
  • Decreased Appetite

Bydureon

  • Nausea
  • Diarrhea
  • Headache
  • Vomiting
  • Constipation
  • Injection Site Reactions

Practical Information

Ozempic

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 56 days
  • Needle Info: Comes with NovoFine® Plus needles

Insurance & Coverage

Widely covered for diabetes, may require prior authorization for weight management

Clinical Results

  • Weight Loss: 12-14%
  • Study Duration: 68 weeks
  • Study: STEP 1 clinical trial

Bydureon

Storage & Handling

  • Storage: Refrigerate until use, do not freeze
  • Needle Info: Comes with needles in kit

Insurance & Coverage

Generally covered for diabetes treatment

Clinical Results

  • Weight Loss: 2-4%
  • Study Duration: 24 weeks
  • Study: DURATION clinical trials

Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.

ShotWise App Interface

Track Your GLP-1 Journey with ShotWise

Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.

Download ShotWise